The importance of targeted next-generation sequencing based genomic profiling in the diagnosis of childhood acute myeloid leukemia: a single center experience
Targeted NGS results, along with well-known genetic aberrations and treatment responses, can guide treatment modalities. The coverage of the routine panels should include proven mutations of childhood AML and germline leukemia predisposition genes.
Authors
- Ayça Koca Yozgat (ORCID: https://orcid.org/0000-0001-6690-721X)
- Büşranur Çavdarlı (ORCID: https://orcid.org/0000-0002-0953-6210)
- Dilek Kaçar (ORCID: https://orcid.org/0000-0003-0825-8316)
- Melek Işık (ORCID: https://orcid.org/0000-0002-7503-303X)
- Neşe Yaralı (ORCID: https://orcid.org/0000-0001-5488-2385)
- Fatma Burçin Kurtipek (ORCID: https://orcid.org/0000-0001-9382-3927)
- Turan Bayhan (ORCID: https://orcid.org/0000-0001-5793-5606)
- Dilek Gürlek Gökçebay (ORCID: https://orcid.org/0000-0001-8097-3950)
- Namık Yaşar Özbek (ORCID: https://orcid.org/0000-0001-6857-0681)
- Fatma Tuba YILDIRIM (ORCID: https://orcid.org/0000-0003-2584-3066)
Institutions
- University of Health Science (KH)
- Sağlık Bilimleri Üniversitesi (TR)
- Ankara Yıldırım Beyazıt University (TR)
Publication Details
- Journal
- The Turkish Journal of Pediatrics
- Published
- 2024-12-18
- DOI
- https://doi.org/10.24953/turkjpediatr.2024.4699
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00